Aspirin may reduce elevated risk of cancer caused by obesity
the ONA take:
Taking aspirin regularly can negate the increased the risk for developing colorectal cancer in patients with Lynch syndrome, according to a new study published online ahead of print in the Journal of Clinical Oncology has shown.
"This is important for people with Lynch Syndrome but affects the rest of us too. Lots of people struggle with their weight and this suggests the extra cancer risk can be cancelled by taking an aspirin," Professor Sir John Blum, professor of Clinical Genetics at Newcastle University in Leeds, UK, said.
For the study, researchers enrolled 937 patients with Lynch syndrome and randomly assigned them to receive aspirin 600 mg per day or placebo, plus resistant starch 30 g per day or placebo. Results showed that during a median follow-up of 55.7 months, the risk of colorectal cancer was nearly 2.5 times higher for overweight participants than for underweight and normal-weight participants.
Obese patients had a 1.77 times increased risk of Lynch syndrome-related cancer compared with normal-weight participants.
The findings suggest that overweight patients with Lynch syndrome are likely to benefit from obesity prevention and/or regular aspirin.
Taking aspirin regularly can negate the increased the risk for developing colorectal cancer in patients with Lynch syndrome.
- Novel Colonoscopy Prep Is Poised to Improve Screening Rates for Colon Cancer
- Short-Term Intervention May Have Long-term Diet Effect in Hispanic Breast Cancer Survivors
- Childhood Cancer Linked to Poor Diet Quality in Adult Survivors
- Low-Dose Sublingual Fentanyl Safe, Effective in Patients Receiving Lower Opioid Doses
- Panobinostat Modestly Improves OS in Relapsed Multiple Myeloma
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Implementing a Distress Screening Process for Cancer Patients
- Initiating Palliative Care in the Emergency Department
- Study Suggests More Men With Prostate Cancer Would Choose Active Surveillance if it Were Offered
- The Bounty of Failure: A Well-Versed Nursing Experience
- Olaratumab in Combo With Doxorubicin Approved for Soft Tissue Sarcoma
- POLST Programs Can Benefit from the Relationship Between Patients and Nurse Practitioners
- Hydroxyurea May Improve Kidney Function in PV-Associated Nephrotic Syndrome
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|